Table 1.

Patients’ medical status

	HCC (n = 20)	mCRC (n = 22)
Sex	92% men	75% men
Age	65 ± 12	58 ± 11
Tumor histology	56% well differentiated, 35% moderately differentiated, 9% undifferentiated	82% adenocarcinoma, 18% colloid adenocarcinoma
Tumor size (cm)	4 ± 3	2 ± 1
Liver metastases		1–5
Associated hepatic pathologies (SA successful amplification)	Alcoholic cirrhosis (n = 8; 4 SA) Hemochromatosis (n = 5; 4 SA)
Previous chemotherapy	Chemoembolization (n = 2; 0 SA) Epirubicin/cisplatin/5FU (n = 1; 1 SA)	Folfox (n = 4; 3SA) Folfiri (n = 4; 1 SA) 5-FU (n = 1; 1 SA)